BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 68 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,664,837 | -23.4% | 1,364,666 | -12.7% | 0.01% | -28.6% |
| Q2 2023 | $25,655,839 | -4.9% | 1,562,475 | -3.3% | 0.01% | -12.5% |
| Q1 2023 | $26,990,978 | +5441.9% | 1,615,259 | +5017.4% | 0.01% | – |
| Q4 2022 | $487,033 | -35.1% | 31,564 | -37.2% | 0.00% | – |
| Q3 2022 | $750,000 | -32.4% | 50,261 | -25.6% | 0.00% | – |
| Q2 2022 | $1,110,000 | -38.3% | 67,539 | -24.7% | 0.00% | – |
| Q1 2022 | $1,799,000 | -29.2% | 89,691 | -10.5% | 0.00% | -100.0% |
| Q4 2021 | $2,540,000 | +3.5% | 100,168 | +10.2% | 0.00% | 0.0% |
| Q3 2021 | $2,453,000 | -10.1% | 90,916 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $2,730,000 | +49.8% | 94,393 | +36.2% | 0.00% | – |
| Q1 2021 | $1,822,000 | -3.5% | 69,284 | +5.1% | 0.00% | -100.0% |
| Q4 2020 | $1,888,000 | +116.8% | 65,891 | +80.5% | 0.00% | – |
| Q3 2020 | $871,000 | +105.9% | 36,507 | +80.6% | 0.00% | – |
| Q2 2020 | $423,000 | – | 20,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |